Search results
Results from the WOW.Com Content Network
Ubrogepant, sold under the brand name Ubrelvy, is a medication used for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. [4] [5] It is not indicated for the preventive treatment of migraine. [6] Ubrogepant is a small-molecule calcitonin gene-related peptide receptor antagonist.
The Institute employs more than 300 people at its research hub at the MaRS Centre in downtown Toronto and funds more than 1,900 scientific staff at hospital-based research institutes and universities around the province. In 2018 it was the highest funder of cancer research in Canada. [3]
Its member institutions undertake 80 per cent of all competitive university research in Canada, and represent a research enterprise valued at more than $5 billion annually. [1] Together, they contribute upwards of C$36 billion to the Canadian economy every year, and produce more than 70 per cent of all doctorates awarded in Canada.
In 2006, Canadian universities spent C$10.890 billion on research and development, representing about 40 percent of all R&D spending in Canada and about .66 percent of Canada's GDP. Below are the names of those university institutions that carry out both natural and social science research, although the emphasis here is on the former.
Experimental cancer treatments are normally available only to people who participate in formal research programs, which are called clinical trials. Occasionally, a seriously ill person may be able to access an experimental drug through an expanded access program. Some of the treatments have regulatory approval for treating other conditions.
The approval allows the use of the cancer drug, Rybrevant, in combination with J&J's existing drug, lazertinib, as a first-line treatment for non-small cell lung cancer (NSCLC) patients with a ...
The most common chronic treatment method is the use of medicine. Many people try to seek pain relief from analgesic medicines (commonly termed pain killers), such as aspirin, acetaminophen, aspirin compounds, ibuprofen, and opioids. [6] The long term use of opioids; however, appears to result in greater harm than benefit. [7]
CIHR was created by an Act of Parliament on June 7, 2000, [6] bringing together existing government activities. CIHR's annual budget is approximately $1.2 billion. [7] [8]In 2021, Carrie Bourassa, the scientific director of CIHR's Indigenous health arm, was placed on immediate leave after the Canadian Broadcasting Corporation (CBC) found no evidence to support her repeated claims of Indigenous ...